Navigation Links
Diabetes Alliance to Feature 17 Presentations for Linagliptin and Investigational Compound Empagliflozin^ During the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD)


This press release contains forward looking statements about empagliflozin, an investigational compound being studied for the treatment of type 2 diabetes, and linagliptin, a DPP-4 inhibitor approved for the treatment of type 2 diabetes along with diet and exercise. It reflects Lilly's current beliefs; however, as with any such undertaking, there are substantial risks and uncertainties in the process of drug development and commercialization. There is no guarantee that future study results and patient experience will be consistent with study findings to date, or that linagliptin will be commercially successful, or that empagliflozin will receive regulatory approvals or prove to be commercially successful or that empagliflozin will receive regulatory approvals or prove to be commercially successful. For further discussion of these and other risks and uncertainties, please see Lilly's latest Forms 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.


Catherine London
Associate Director, Public Relations
Boehringer Ingelheim Pharmaceuticals, Inc.
Phone: (203) 798-4638

Tammy Hull
Communications Manager
Lilly Diabetes
Phone: (317) 651-9116


1.   EASD 2013 online program, Accessed: 
2.   TRADJENTA® (linagliptin) tablets. Highlights of Prescribing Information. June 2013.
3.   International Diabetes Federation. IDF Diabetes Atlas,

SOURCE Eli Lilly and Company; Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
2. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
3. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
4. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
5. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
6. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
7. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
8. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
9. JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes
10. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
11. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Post Your Comments:
(Date:1/23/2015)... to Fight Chronic Disease (PFCD) released a public opinion poll of ... study analyzing the impact of increased cost sharing on patient adherence ... educate policy makers and the public on the costs of chronic ... the Iowa healthcare exchange could be improved ...
(Date:1/23/2015)... ATLANTA , Jan. 23, 2015 More than a ... a quarter of those with private insurance, filled a prescription ... to a report in this week,s Morbidity and Mortality Weekly ... health care providers to treat moderate to severe pain.  They ...
(Date:1/23/2015)... GAINESVILLE, Fla. , Jan. 23, 2015  HyGreen, Inc., ... distribution agreement and partnership with RCA Medical, a subsidiary ... Africa . Each year, hundreds of ... health care-associated infections as organisms are transmitted from patient ...
Breaking Medicine Technology:New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3HyGreen Partners with RCA Medical in Johannesburg, South Africa 2
... 2012   Unigene Laboratories, Inc. (OTCBB: UGNE) , ... development of peptide-based therapeutics, today announced the Company,s Vice ... be presenting at the TIDES 2012 conference for the ... Bay Resort and Casino in Las Vegas, NV. ...
... 21, 2012   Cerecor Inc. , a biopharmaceutical company ... pharmaceuticals whose primary activity is in the human nervous ... FP01 lozenges in CLIN01-002-A, an exploratory Phase ... respiratory tract infections (URTI).  "The data we plan to ...
Cached Medicine Technology:Unigene to Present at TIDES 2012 2Unigene to Present at TIDES 2012 3Cerecor Announces Initiation of CLIN01-002-A 2
(Date:1/22/2015)... 2015 Deer Path of Huntley -- ... Day Happy Hour from 3 p.m. to 4 p.m. on Feb. ... in Huntley, Illinois, serves adults with physical disabilities between the ages ... Valentine's Day treats, games and sweetheart-themed karaoke. , For more information ...
(Date:1/22/2015)... The City of West Hollywood hosted a news conference on ... anniversary of the Supreme Court decision Roe v. Wade, which legalized ... the Roe vs. Wade decision and the fight to protect a ... City of West Hollywood Councilmember Abbe Land. “We need to continue ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently ... thrilled to have it lead the wedding dress industry into ... prom dresses for the global market. , “The CEO of ... he focuses on continuing the goal of operational excellence and ...
(Date:1/22/2015)... the premier women’s dress supplier, has recently released its ... of to find more details. , Many ... a bridal party. AngelWeddingDress offers a variety of gorgeous ... wedding dresses are specially designed for 2015. , AngelWeddingDress ...
(Date:1/22/2015)... 2015 Thousand of GranuFlo lawsuits ( ... its GranuFlo and NaturaLyte dialysis concentrates continue to move ... District Court, District of Massachusetts, Bernstein Liebhard LLP reports. ... has remanded a case filed by the state of ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4
... PRINCETON JUNCTION, N.J., July 21 Lutronic, Inc., a leading developer ... a contract with Lifestyle Lift(C) to become their primary provider of ... Lifestyle Lift(C) is one of the largest medical practice groups ... , Lifestyle Lift(C) chose the eCO2 ...
... , ... Edvantage designed to provide professionals with education to better serve residents, families , ... Wausau, Wisc. (Vocus) July ... and solutions, and the University of Wisconsin-Eau Claire, today announced the creation of the ...
... , , , MINNEAPOLIS, ... Elite top agency, announced that it has entered into a ... telehealth and disease management technology to patients with chronic illness. ... developer, manufacturer and clinical service provider of award-winning telehealth solutions. ...
... , , , , ... food company, today announced the launch of TLC(R) Dark Mocha Almond Chewy ... TLC(R) Chewy Granola Bar family. This new granola bar combines crunchy ... , , (Logo: ) ...
... to open an R&D facility and manufacturing plant in China, ... products to the fastest, growing pharmaceutical market ... /PRNewswire-FirstCall/ - AlphaRx (OTC BB:ALRX - News), an emerging biopharmaceutical ... of drugs, is forging ahead with its growth strategy for ...
... July 21 Three Wishes, Inc., a medical supply company here ... plans. , , The company has been acquired by ... Chief Operating Officer of Three Wishes. , , "We,re ... "and we,re well on the way. Since January of this year, ...
Cached Medicine News:Health News:Lutronic(R) Becomes Official Laser for Lifestyle Lift(R) 2Health News:My InnerView and UW-Eau Claire Announce New Online Health Management Certificate Program for Senior Care Professionals 2Health News:My InnerView and UW-Eau Claire Announce New Online Health Management Certificate Program for Senior Care Professionals 3Health News:Norwell VNA and Hospice Selects Cardiocom Telehealth as Its New Technology Vendor 2Health News:Kashi Company Introduces TLC(R) Dark Mocha Almond Chewy Bar 2Health News:AlphaRx Unveils its China Strategy 2
A versatile plate washer and/or dispenser that aspirates from the top down without immersing the aspirating tubes in the well, ensuring overflow protection. 5 programmable protocols....
The Finstrip 4 is an effective and reliable microplate washer offering high performance, simplicity and ease of use....
... Bio-Rad's Model 1575 immunowash ... control of needle position ... routines and maximize wash ... a large choice of ...
... a solid made, manual plate washer ... for dispense and aspirate function ensure ... with a stand and all necessary ... used, as well as any bottles ...
Medicine Products: